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Cancer is the second-most leading cause of death in the United States, with 1.66 million 
new cases expected to be diagnosed and over 580,000 Americans expected to die of 
cancer in 2013 alone. (American Cancer Society 2013)  Current treatments result in 
damage to the healthy tissues and incomplete resections of solid tumors, but by 
harnessing nanotechnology, more effective treatments can be constructed.  Gold 
nanoshells present a promising option for targeted cancer therapy.  The anatomy of 
tumors causes the “enhanced permeability and retention” effect, which means that nano-
scale particles will extravasate from the bloodstream and accumulate in the tumors.  
However, small nanoparticles must still diffuse from the tumor vasculature into the tumor 
tissue.  Due to impaired vascularization, the particles are unable to reach into the entire 
tumor region. The purpose of our project is to create a “two-layer” nanoshell coated with 
alkanethiol and phosphatidlycholine and a “three-layer” nanoshell that coats the “two-
layer” system with a layer of high-density lipoprotein.  It is proposed that these coatings 
will allow for better penetration of solid tumors compared to the standard nanoshells 
modified with poly(ethylene glycol) (PEG).   In addition to the nanoshells, citrate-gold 
nanoparticles were investigated as a control.  Size, zeta potential, and morphology were 
optimized, and the penetration of the particles into solid tumors was investigated using 
dark-field microscopy.  It was discovered that the “two-layer” nanoshells exhibited 
significantly more uptake into the solid tumors compared to PEGylated nanoshells, and 
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 Cancer is the second most common cause of death in the United States, 
(American Cancer Society 2013) with an estimated 580,000 Americans dying of cancer 
in 2013 alone. (American Cancer Society 2013)  There are also an estimated 1,660,000 
new cancer diagnoses expected this year. (American Cancer Society 2013)  While 
advances in early diagnostics and treatment methods have increased the five-year 
survival rate to 68% for 2002 – 2008, more advances in treatment methods are necessary 
to effectively treat cancers and further raise the survival rates. (American Cancer Society 
2013)  The application of nanotechnology to better deliver therapeutic agents to the 
tumor regions has attracted a vast amount of research.  Solid tumors have several 
characteristics that differ from healthy tissue, including excessive angiogenesis.  
Nanoparticles and drugs on the nano scale (60 – 400 nm) exhibit increased extravasation 
into the interstitial space of solid tumors due to a passive mechanism termed the 
“enhanced permeability and retention” (EPR) effect. (Kong, Braun et al. 2000, Maeda 
2001)  While the concept seems trivial, the targeted delivery of anticancer drugs (targeted 
chemotherapy) using nanoparticles is a major research goal.  Targeted treatments both 
increase the effectiveness of the drugs while simultaneously reducing the systemic toxic 
side effects to the patient.  However, there are many factors that dictate the effectiveness 
of a nanoparticle system in reaching the tumor regions within a patient.  The particle size, 
surface charges, and morphology all contribute to the pharmacodynamics and 
cytotoxicity of the nanoparticle system. (Murphy, Gole et al. 2008, Zamboni, Torchilin et 
al. 2012)  These properties must be tailored in order to design a nanoparticle system that 





 Gold nanoparticles have exhibited some of the more promising research in recent 
years.  Bulk gold itself is an inert material, though gold nanoparticles smaller than 5nm in 
diameter have documented cytotoxic properties. (Alkilany and Murphy 2010, Kennedy, 
Bickford et al. 2011)  However, larger particles have been demonstrated to display little 
cytotoxicity, depending on the surface charge. Cationic particles are more cytotoxic at 
lower concentrations compared to anionic nanoparticles; this has been attributed to 
electrostatic interactions of the positively-charged particles with the negatively-charged 
cell membrane. (Goodman, McCusker et al. 2004)  In addition, surface coatings of 
poly(ethylene glycol) (PEG) effectively “mask” the nanoparticles from the immune 
system, further lowering cytotoxicity. (Murphy, Gole et al. 2008, Kennedy, Bickford et 
al. 2011) 
 The major advantages of a gold nanoparticle system are the relative ease of 
synthesis and the tunable nature of the optical properties of the nanoparticles.  The 
Turkevich method has been used to synthesize colloidal gold for many years, and results 
in nanoparticles with a narrow size distribution that is easily tunable based on the ratio of 
the reactants. (Frens 1973)  A sharp absorption profile is observed in the 520 – 540 nm 
range. (Turkevich, Stevenson et al. 1951, Frens 1973, Turkevich 1985)  The optical 
properties of gold nanoparticles prepared via the Turkevich method can only be tuned to 
a limited degree.  However, gold nanoshells, which consist of a silica core coated with a 
thin layer of gold, exhibit easily tunable optical properties and can be applied as imaging 
contrast agents (Loo, Lowery et al. 2005), therapeutic agents (Gobin, Watkins et al. 
2010), or combined imaging and therapeutic agents (Gobin, Lee et al. 2007).   By varying 





selected, from infrared through the spectrum of visible light. (Oldenburg, Averitt et al. 
1998)  Early work with gold nanoshells produced a system coated with poly(vinyl 
alcohol) (PVA) that exhibited a peak absorption at 800 nm, in the near-infrared (NIR) 
region of light. (Oldenburg, Jackson et al. 1999)  Near-infrared light is not considered 
harmful when directed at tissues, as the heating effect is very minimal. (Ito, Kennan et al. 
2000)  However, as metallic particles absorb wavelengths of light, they begin to resonate, 
releasing the energy as heat.  To apply this concept to cancer therapies, PEGylated gold 
nanoshells were coupled with a NIR-emitting laser.  The combination of nanoshells and 
NIR treatment effectively caused irreversible tissue damage to solid tumors in vivo due to 
sustained hyperthermia, while NIR treatment alone did not result in any adverse effects. 
(Hirsch, Stafford et al. 2003)  Current clinical trials are underway, testing the efficacy of 
the gold nanoshell-mediated hyperthermia treatments. (Pilot Study of AuroLase Therapy 
2013) 
 
A. PURPOSE OF THE RESEARCH 
 NIR-absorbing gold nanoshells are proven to be effective at killing solid tumors 
due to hyperthermia when treated with a NIR laser.  However, the nanoshells have been 
PEGylated in all previous investigations of their potential.  Phosphatidlycholine (PC) has 
been used as a passivating agent for gold nanorods, significantly reducing their 
cytotoxicity. (Takahashi, Niidome et al. 2006)  In addition, PC is the most abundant 
phospholipid within the body and can be found in all cell membranes.  The structure of 





negatively charged phosphate groups are oriented on the outside of the layer, resulting in 
an anionic surface charge. 
 
Figure 1 – Structure of L-α-phosphatidlycholine isolated from soybeans. 
 
 In order to form a layer of PC around the gold nanoshells, a hydrophobic layer 
must also be created.  Thiol groups exhibit strong binding to gold, and can be used to 
displace other stabilizing ligands and adsorbed molecules to stabilize the particle.  An 
alkanethiol possesses the optimal qualities for this; the hydrophobic carbon chains will 
interact with the fatty acids of the PC to form a properly oriented layer.  This “two-layer” 
approach was theorized to display better biocompatibility and thus better penetration into 
solid tumors when compared to PEGylated particles.  With the “two-layer” method, a 
hydrophobic region is created between the PC and alkanethiol, which could potentially 
hold hydrophobic drugs to produce a more potent therapeutic agent. 
 A “three-layer” method was also developed; evidence suggests that high-density 
lipoprotein (HDL) uptake in hepatocytes is upregulated in liver cancers. (Jiang, Nilsson-
Ehle et al. 2006)  Adding a layer of HDL around the “two-layer” particles could 
potentially allow the particles to penetrate more deeply into liver cancers as the surface 
modifications make uptake by the hepatocytes more likely rather than just relying on the 
EPR effect to passively accumulate particles within solid tumors. 
 The purpose of developing the “two-” and “three-layer” nanoshells are to directly 





PEGylated AuroShells™.  In addition, the depth of penetration of “two-layer,” “three-
layer,” and PEGylated citrate-gold nanoparticles are also compared to the nanoshells.  
While citrate-gold nanoparticles are much smaller than the silica-core gold nanoshells, 
they do not exhibit absorption in the NIR range and cannot be used for photothermal 
ablation therapy. 
 This study is focused on identifying the number of particles within the solid 
tumors at varying depths of penetration.  By accurately counting the amount of particles 
within specific regions of tissue, a diffusion gradient can be constructed and combined 
with mathematical modeling to better understand the effectiveness of these particles for 
cancer treatment.  The experimental results can then be utilized to calibrate the complex 
computational simulations involved with the dynamics of solid tumor interactions. (van 







A. SYNTHESIS OF SILICA-CORE GOLD NANOSHELLS 
Gold nanoshells were prepared according to previously established methods. 
(Gobin, Lee et al. 2007)  
i. SYNTHESIS OF SILICA CORES 
The silica cores were grown according to the Stöber process, using tetraethyl 
orthosilicate (TEOS) in ethanol. (Stöber, Fink et al. 1968)  A round bottom flask was 
filled with 225mL 200proof ethanol, and the liquid was stirred.  12.5mL of fresh 
ammonia was then added to the ethanol to provide the basic environment required for the 
reaction to proceed.  Three minutes after the addition of ethanol, 7.5mL of TEOS was 
added to the flask, and the mouth of the flask was immediately covered with paraffin.  
After reacting for 24 hours, the paraffin was removed from the mouth of the flask to 
allow the excess ammonia to evaporate.  The completed silica cores measure 
approximately 110nm in diameter, on average. 
ii. APTES MODIFICATION OF SILICA CORES 
 The silica cores were modified by coating with aminopropyltriethoxysilane 
(APTES).  Prior to modification, 15mL of silica cores were placed in a 50mL 
polypropylene tube and centrifuged at 1500xg for 20min.  The supernatant was then 
removed, and the pellets combined.  The tubes were then washed with ethanol and 
sonicated for 20 min prior to centrifugation at 1200xg for 20 min.  All of the pellets were 





APTES was added to the silica cores, and solution was sonicated for 120 min at elevated 
temperature, before being placed on the rocker bed for 20 hours. 
 The cores were then centrifuged at 1000xg for 20 min, and the supernatant 
discarded.  The pellet was resuspended in 50% ethanol (in dH2O) and sonicated for 20 
min.  The washing step was then repeated to finish the modification of the silica cores. 
iii. SYNTHESIS OF THPC COLLOID 
A gold colloid solution was also prepared, in order to coat the completed silica 
cores. (Duff, Baiker et al. 1993)  A stock solution of the reducing agent for the colloidal 
gold was prepared.  0.4mL of tetrakis(hydroxymethyl)phosphonium chloride (THPC) 
was added to 33mL of distilled H2O (dH2O) and stirred for approximately 5 minutes.  A 
500mL plastic beaker was then filled with 180mL of cold dH2O.  To this solution, 1.2mL 
of 1M NaOH and 4mL of the THPC stock solution were added while stirring.  Finally, 
6.75mL of 1%/wt HAuCl4 in dH2O was quickly added to the solution, and after 1 minute 
of agitation, the reaction was halted.  The THPC-gold colloid solution was then stored in 
a 275mL plastic flask at 4°C.  The THPC-gold colloid was aged at 37°C for at least 4 
days prior to use in order to ensure proper colloid growth and concentrated 10x via rotary 
evaporation before use. 
 
iv. NANOSHELL SEED FORMATION AND GOLD SHELL REDUCTION 
 In a 50mL polypropylene tube, 20mL of concentrated THPC colloid was reacted 
with the APTES-modified silica cores and sonicated for 60 min.  The reaction was then 





minutes and the pellet collected.  The pellets were combined and resuspended in 20mL 
dH2O, then centrifuged again at 600xg for 20 minutes.  The pellet was then resuspended 
in 20mL dH2O, and the optical intensity of the seeds was measured via UV-vis 
spectroscopy.  The seeds were diluted an optical density (OD) of 0.5 at 530nm.  A 
K2CO3-HAuCl4 (KCarb) solution was prepared by combining 50mg K2CO3 with 200mL 
dH2O and 3mL 1% wt/v HAuCl4.  A sweep of the seeds was performed to optimize the 
reaction amounts of KCarb, seeds, and formaldehyde (the reducing agent) for the final 
gold shell reduction in order to produce the most desired optical properties.  The seeds 
were then mixed with optimal amounts of KCarb and formaldehyde to complete the gold 
nanoshells. 
 
B. SYNTHESIS OF CITRATE-STABILIZED GOLD NANOPARTICLES 
Colloidal gold nanoparticles were also prepared according to published methods.  
The particles were formed according to a modified Turkevich synthesis. (Turkevich, 
Stevenson et al. 1951, Frens 1973)  A stock solution of 1%/wt HAuCl4 in distilled H2O 
was prepared.  This stock solution was diluted to 0.01%/wt HAuCl4, and 200mL was 
added to a 250mL Erlenmeyer flask.  The solution was then brought to a boil in a water 
bath under vigorous stirring, and kept boiling for 10 minutes.  A 2.3mL solution of 1%/wt 
sodium citrate in distilled H2O was added to the boiling gold solution, and the reaction 
was carried out for approximately 15 minutes while boiling.  The reaction solution shifted 
colors from pale yellow to a red/reddish-purple color, indicating that the conversion of 
ionic gold into colloidal gold had been achieved.  The solution was then cooled to room 






C. SURFACE MODIFICATIONS OF PREPARED PARTICLES 
Both the prepared nanoshells and citrate-gold nanoparticles were modified to 
produce “two-layer,” “three-layer,” and PEGylated particles.   
 
i. MODIFICATION WITH POLY(ETHYLENE GLYCOL) 
 The prepared particles were modified with poly(ethylene glycol) (PEG) to form 
the control group.  PEGylated particles have been shown to have stealth properties with 
the immune system. (Gobin, Lee et al. 2007)  The optical density of the nanoparticles was 
determined using absorbance spectroscopy, measuring wavelengths from 400 – 1100nm.  
1μL of a 20mM PEG-thiol solution was added for every 1 OD/mL of the particle 
solution.  The gold-sulfur bond forms spontaneously, and is a very strong bond.  The 
sample was then sonicated for 10 minutes, and left on a rocker plate overnight.  The 
PEGylated particles were then centrifuged at 300xg for 15 minutes to separate the excess 
PEG.  The supernatant was removed, and the pellet collected and redispersed in dH2O to 
the optimal optical density. 
 
ii. “TWO-LAYER” PARTICLE MODIFICATION 
“Two-layer” particles were formed by first modifying the particles with an 
alkanethiol.  Two 50mL polypropylene tubes were each filled with 25mL of ethanol 





nanoshell/citrate-gold nanoparticle solution was added.  The tubes were then sonicated 
for 60 minutes, and left overnight on a rocker plate.  As the sulfur of the alkanethiol 
reacts with the gold surfaces and spontaneously forms strong gold-sulfur bonds, the 
particles become hydrophobic, creating a film on the sides of the tubes and on the surface 
of the liquid.  The solutions were centrifuged at 300xg for approximately 14 minutes, in 
order to form a pellet.  The supernatant was then removed, and the tube washed with 
20mL ethanol before a second centrifugation at 300xg for 14 minutes.  The supernatant 
was removed again, and the tubes were left to air dry.  Once the ethanol evaporated from 
the tubes, 10mL CHCl3 was added to each tube.  CHCl3 is an organic, slightly polar 
solvent, and the hydrophobic thiol-stabilized particles are soluble in the solvent.  The 
tubes containing thiol-stabilized particles in CHCl3 are then sonicated for 60 minutes to 
ensure that the particles are redispersed. 
After sonication, 150uL of 25mg/mL soy phosphatidlycholine (PC) in CHCl3 was 
added to the tubes, which were then left on the rocker plate overnight.  The hydrophobic 
tails of the PC interact with the exposed carbon chains of the particles, forming a 
complete layer of PC around the particles, causing them to become hydrophilic as only 
the polar headcaps of the phospholipid are exposed in solution.  Once the PC has coated 
the particles, the solution was placed into glass test tubes and dried under air to allow the 
CHCl3 to evaporate.  Once tubes were dry, the particles were redispersed in 5mL dH2O 
and sonicated for 60 minutes and combined in.  In order to remove the particles that were 
not fully coated with PC, the solutions were centrifuged at 300xg for 15 minutes.  The 
supernatant was removed and collected, and the tube was then washed with dH2O before 





again, and the collected supernatant combined and placed in a new 50mL polypropylene 
tube.  The “two-layer” (thiol-PC) particles are complete at this stage, and an aliquot was 
taken for characterization by absorbance spectroscopy, DLS and SEM.  The desired 
optical density (OD) of the particles was then reached by diluting the sample with dH2O. 
 
iii. “THREE-LAYER” PARTCLE MODIFICATION 
The “three-layer” (thiol-PC-LP) particles were then prepared by the addition of 
high-density lipoprotein (LP) derived from human plasma to the completed “two-layer” 
particles.  The LP sticks to the surface layer of the “two-layer” particles, and potentially 
becomes interspersed within the phosphatidlycholine layer.  To a 4.5mL sample of the 
“two-layer” particles, 3mg LP was added per 20OD.  The solution was then sonicated for 
10 minutes and left overnight at 4°C.  An aliquot was taken for characterization by 
absorbance spectroscopy, DLS and SEM, and the completed “three-layer” particles were 
diluted to the desired optical density with dH2O. 
 
D. INCUBATION OF PARTICLES WITH TUMOR SPHEROIDS 
Spheroids comprised of cancer cells from three different cell lines were utilized to 
test the diffusion of the different particle compositions and modifications.  HEPG2 (liver 
hepatocellular carcinoma), A549 (human lung adenocarcinoma), and S2VP10 (pancreatic 
metastatic adenocarcinoma) spheroids were incubated with 40 uL particles at 25 OD.  
The spheroids typically measured between 0.5 and 2 mm in diameter, though the S2VP10 





lines were chosen due to the hypoxic regions within the center of the tumors, which gives 
rise to necrosis of the cancer tissues.  The cells were incubated with the particles for six 
hours before being washed with PBS, in order to ensure particle penetration into the 
spheroids.  The spheroids were then placed in the cryomolds made of tissue freezing 
medium.  The samples were allowed to dry for two hours, and the sectioned at 5µm using 
a Lecia CM1860 Cryostat.  The sectioned spheroids were then fixed onto Superfrost Plus 
microscope slides.  The successful fixation of the spheroid to the slide was determined 
via bright-field microscopy.  Excess media was removed from the slides by soaking with 
30% Neutral Buffered Formalin for 1 minute.  The slides were then washed in DI water 
prior to analysis. 
 
E. CHARACTERIZATION OF PARTICLE PROPERTIES 
The prepared particles were analyzed with scanning-electron microscopy (SEM), 
zeta-potential analysis, and UV-vis absorbance spectroscopy in order to determine the 
characteristics of the particles. 
 A Zeiss Supra 35VP SEM was used to characterize size and morphology of the 
particles.  An aliquot of the prepared particles was taken in order to perform absorbance 
spectroscopy and zeta-potential analysis.  100μL of the particles was diluted with 900 μL 
of dH2O in order to form a 10x dilution of the original sample.  This dilution was then 
placed in a clear, plastic 1 cm cuvette, which was inserted into a Varian Cary 50 Bio UV-
Visible Spectrophotometer.  The sample was scanned from wavelengths of 400 – 1100 





multiplied by a factor of 10 to determine the optical density of the sample.  The OD was 
used to determine the optimal amounts of layering agents needed during the synthesis of 
the modified particles.  The sample was then transferred to a Malvern Zetasizer Nano 
ZS90 for automated zeta-potential analysis with the Malvern software tools. 
F. OPTICAL ANALYSIS VIA DARK-FIELD MICROSCOPY 
An Olympus BX43, fitted with a condenser from Cytoviva, was utilized for the 
dark-field microscopy.  Images were captured at 60x magnification using a Dage 
XLMTC optical camera.  The system is depicted in Figure 2.  The samples were prepared 
again by soaking in cold acetone, 10% neutral buffer formalin, and dipping in dH2O.  
Once the slides were dried, the region around the tissue was identified by bright-field 
microscopy and marked for ease of identification.  A drop of oil was placed on the slide 
and a coverslip attached.  A drop of oil was then placed on the condenser, and the 
condenser was brought into contact with the slide.  The light source was focused and 
aligned at 10x magnification in order to produce the best quality images.  Another drop of 
oil was placed on top of the coverslip, and an oil-immersion 60x magnification objective 






Figure 2 – Setup of the Olympus BX43 microscopy system. 
 
Images were captured at 12-bit resolution at a size of 2048x2048 pixels using 
Dage Xponent7.  At a magnification of 60x, a distance of 1um measured to 8.1 pixels.  
However, given the light-scattering properties of the nanoparticles, they appear larger 
than their actual size and are easily identified, especially when forming aggregated 
complexes.  All image analysis was performed using NIH ImageJ.  An automatic filtering 
algorithm was applied to all images, which separated out the majority of the particles 
from the background of tissue. (Yen, Chang et al. 1995)  To ensure that no particles were 
inadvertently filtered, measurements were taken utilizing both the original and the filtered 
image simultaneously. 
Images of nanoparticles alone were used to determine the average appearance of 





interest (ROI) intensity was recorded.  The number of particles was then manually 
counted, and the ROI intensity was divided by the particle count in order to determine the 
average size particle. 
  
Figure 3 – Dark field image of “two-layer” nanoshells. 
 
The number of particles present within a given area was then manually counted, using 
this average particle size for reference in order to form a reasonable estimate in the case 
of aggregated particles within the tissue.  Regions located at varying depths of 
penetration from the periphery of the spheroid were analyzed on each image in order to 
visualize the diffusion gradient of the nanoparticles into the center of the cancer tissues.  
The results were then compared internally to determine if a particular particle 








V. RESULTS AND DISCUSSION 
 The nanoparticles were characterized with UV-vis absorbance spectroscopy, zeta 
potential analysis, and scanning electron microscopy to ensure that proper particle 
formation and modification was achieved. 
 The optical and charge measurements are displayed in Figure 4, and indicate that 
all of the surface modifications were successful.  Prepared citrate-gold nanoparticles (A) 
had a peak absorbance of 535nm, which is consistent with literature. (Kimling, Maier et 
al. 2006)  The silica-gold nanoshells (B) exhibited peak absorbance at 810nm.  The 
nanoshells demonstrated ideal optical properties for use in near-infrared experiments 
(O'Neal, Hirsch et al. 2004, Gobin, Lee et al. 2007), though NIR treatments were not 
included in the scope of this work.  In order to verify the surface modifications of the 
nanoparticles, the zeta potential was measured.  Surface modification with 
phosphatidlycholine and thiol result in more highly negatively charged particles 
compared to PEGylated particles.  Conversely, the high-density lipoprotein causes the 
zeta potential of the particles to become more positively charged when compared to 
PEGylated particles, but still results in slightly negatively charged particles.  The 
measured zeta potential of all particle types is displayed in (C).  The PEGylated citrate 
gold nanoparticles exhibited a zeta potential of -9 mV, while the “two-layer” citrate gold 
nanoparticles had a zeta potential of -20 mV and the “three-layer” citrate gold 
nanoparticles -2 mV.  The gold nanoshells exhibited consistently higher surface charge 
than the citrate gold nanoparticles, which is consistent with the larger size of the 





measured a zeta potential of -29 mV, and the “three-layer” nanoshells a zeta potential of -
6.8 mV. 
 
Figure 4 - Characterization of the Citrate Gold Nanoparticles and Gold Nanoshells 
by UV-Visible Spectrometry and Zeta Potential Analysis. 
 
 
 Scanning electron microscopy (SEM) was used to determine the size and 
morphology of the particles (Figure 5).  The shape of nanoparticles has been 
demonstrated to affect the particle uptake into tissues. (Kennedy, Bickford et al. 2011)  
Both the citrate-gold nanoparticles and gold nanoshells are spherical, which is desired to 










Figure 5.  Scanning Electron Images of Functionalized Citrate-Gold Nanoparticles 
and Gold Nanoshells. (England et al., in prep.) 
 
The PEGylated gold nanoshells (A) have spherical morphology and are ~150nm 
in diameter.  The addition of organic compounds onto the surface of the gold nanoshells 
is evidenced by a “halo” effect around the particles for both the “two-layer” (B) and 
“three-layer” (C) particles.  Citrate gold nanoparticles are much smaller than nanoshells, 
measuring ~50nm in diameter.  Aggregation was more prevalent with citrate gold 
nanoparticles, as evidenced by the PEGylated particles (D).  This aggregation is due to 
the decreased zeta potential of citrate gold nanoparticles when compared to the gold 
nanoshells.  The “two-layer” (E) and “three-layer” (F) nanoparticles also exhibited the 
“halo” effect, indicating the presence of organic material on the surface of the particles.  





nanoshells and LP added another 10 nm to the diameter.  There was no measurable size 
difference between the modified citrate gold nanoparticles.  The evidence of the “halo” 
around the modified particles and the measured increase in size further indicates the 
successful surface modifications of the particles. 
 Modified particles within the sectioned spheroids were observable in the images 
captured via dark-field microscopy.  The particles reflected the light, displaying sharp 
contrast with the surrounding tissue, and could be easily counted.  A representative image 
is displayed in Figure 6, and the arrows pointing to the small red-orange dots indicate the 
position of some particles within the tissue. 
 





 However, to ensure that the particles could be distinguished from the tissue, the 
images were filtered to remove the background via the Yen algorithm. (Yen, Chang et al. 
1995)  The images were considerably clearer after the algorithm was implemented, but 
particles were counted using the filtered and unfiltered images simultaneously to ensure 
that there were not particles inadvertently removed from the count. (Figure 7) 
 






 The uptake and diffusion of particles from the periphery of the tumor spheroids 
into center regions was analyzed via the obtained particle counts from the dark-field 
images, and presented in Figure 8.  The left column lists the citrate-gold nanoparticles, 
while the right column displays the gold nanoshells.  The three different cell lines that 
comprise the spheroids are listed on the left of the graph.  The control particles 
(PEGylated particles) are represented by black diamonds, while the “two-layer” particles 
are represented by gray square and “three-layer” particles by a dark gray triangle.  
 
Figure 8 – Nanoparticle Diffusion into Center Regions of the Spheroids. 
PEGylated: Diamond; “Two-layer”: Square; “Three-layer”: Triangle.  





The measured amount of particles penetrating the spheroids was generally highest 
for the “two-layer” particles.  However, the “three-layer” particles showed slightly higher 
penetration into S2VP10 spheroids, but this could be due to the unique morphology of 
S2VP10, which resembles a cluster of grapes, and other cancer-specific interactions with 
the high-density lipoprotein.  There were no instances where the PEGylated particles 
displayed higher particle penetration into the spheroids compared to “two-layer” or 
“three-layer” particles.  Citrate-gold nanoparticles exhibited approximately 28% more 
particle penetration at the spheroid periphery compared to the gold nanoshells, but this is 
mostly due to the larger size of the gold nanoshells.  Gold nanoshells are three-times the 
size of the citrate-gold nanoparticles.  While the number of particles is lower for gold 
nanoshells, their application for cancer therapy is much greater than citrate-gold 
nanoparticles.  Gold nanoshells possess tunable optical properties, and photothermal 
treatment has shown to reduce cell viability significantly. (Lowery, Gobin et al. 2006, 
Gobin, Lee et al. 2007)  Internally comparing the gold nanoshell results across spheroid 
types, the “two-layer” nanoshells exhibited an average 51% more penetration into the 
spheroids compared to “three-layer” nanoshells.  Both the “two-layer” and “three-layer” 
nanoshells outperformed PEGylated nanoshells, the current standard, handily.  “Two-
layer” nanoshells demonstrated a staggering 325% increase in measured particle 
penetration compared to the current standard, and “three-layer” nanoshells displayed an 
increase of 173% compared to the PEGylated nanoshells.  Rather than PEGylating gold 
nanoshells, modifying the nanoshell with an alkanethiol and phosphatidlycholine creates 
a viable “two-layer” nanoshell platform that consistently outperforms the current standard 









 The work can be continued by examining the efficacy of the “two-layer” 
nanoshell system in photothermal applications and determining its benefits compared to 
PEGylated nanoshells.  In addition, work is currently being done to investigate the 
potential for embedding drugs into the layers of the “two-layer” nanoshell for drug 
delivery.  A more interesting approach would be to combine the photothermal treatments 
with drug delivery.  A system could potentially be designed that would release its drug 
payload once the particle has been excited through NIR light, disrupting the layers on the 
nanoshell.  These steps are the next logical progression towards developing a potent 
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